What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

Gaia Giannone, Andrea Milani, Elena Geuna, Danilo Galizia, Federica Biello, Filippo Montemurro

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalExpert Opinion on Pharmacotherapy
DOIs
Publication statusE-pub ahead of print - Nov 6 2018

Cite this

What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer? / Giannone, Gaia; Milani, Andrea; Geuna, Elena; Galizia, Danilo; Biello, Federica; Montemurro, Filippo.

In: Expert Opinion on Pharmacotherapy, 06.11.2018, p. 1-5.

Research output: Contribution to journalArticle

@article{b9c89d5c244d4fb2b1c45dd6fa248631,
title = "What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?",
author = "Gaia Giannone and Andrea Milani and Elena Geuna and Danilo Galizia and Federica Biello and Filippo Montemurro",
year = "2018",
month = "11",
day = "6",
doi = "10.1080/14656566.2018.1543406",
language = "English",
pages = "1--5",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

AU - Giannone, Gaia

AU - Milani, Andrea

AU - Geuna, Elena

AU - Galizia, Danilo

AU - Biello, Federica

AU - Montemurro, Filippo

PY - 2018/11/6

Y1 - 2018/11/6

U2 - 10.1080/14656566.2018.1543406

DO - 10.1080/14656566.2018.1543406

M3 - Article

C2 - 30396301

SP - 1

EP - 5

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

ER -